CE vs TXMD · rev $10.28B vs rev $1.8M
Celanese Corporation (CE) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
CE currently screens at market cap $5.92B. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the CE and TXMD stock pages for the full models.
Not investment advice.